World's Best Scientists 2026 revealed!
Yuichiro Doki

Yuichiro Doki

D-Index & Metrics

Medicine

D-Index
108
Citations
50092
World Ranking
5938
National Ranking
131

Overview

Yuichiro Doki is affiliated with Osaka University in Japan and has a significant publication record in the field of Medicine, with a particular focus on Surgery, Oncology, and Pulmonary and Respiratory Medicine. Their work spans various subfields including Molecular Biology and Gastroenterology, emphasizing contributions to cancer research and treatment.

The research topics frequently addressed by Yuichiro Doki include:

  • Gastric Cancer Management and Outcomes
  • Esophageal Cancer Research and Treatment
  • Esophageal and GI Pathology
  • Pancreatic and Hepatic Oncology Research
  • Gastrointestinal Tumor Research and Treatment
  • Colorectal Cancer Surgical Treatments
  • Cancer Immunotherapy and Biomarkers

Doki's work appears regularly in several academic journals and publication venues. The most frequent venues are:

  • Annals of Surgical Oncology
  • Esophagus
  • Annals of Gastroenterological Surgery
  • Scientific Reports
  • Surgery Today

Co-authorship collaboration plays a key role in Doki's scientific contributions. Common co-authors include:

  • Hidetoshi Eguchi
  • Yukinori Kurokawa
  • Tomoki Makino
  • Koji Tanaka
  • Shogo Kobayashi

Selected recent papers authored or co-authored include:

  • "CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory," 2022, Proceedings of the National Academy of Sciences
  • "Thoracic and cardiovascular surgeries in Japan during 2017," 2020, General Thoracic and Cardiovascular Surgery
  • "Five-Year Survival Outcomes of Laparoscopy-Assisted vs Open Distal Gastrectomy for Advanced Gastric Cancer," 2023, JAMA Surgery
  • "The Geriatric Nutritional Risk Index predicts postoperative complications and prognosis in elderly patients with colorectal cancer after curative surgery," 2020, Scientific Reports
  • "Thoracic and cardiovascular surgeries in Japan during 2018," 2020, General Thoracic and Cardiovascular Surgery

Best Publications

  • Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial

    Ken Kato;Byoung Chul Cho;Masanobu Takahashi;Morihito Okada

  • Reprogramming of mouse and human cells to pluripotency using mature microRNAs.

    Norikatsu Miyoshi;Hideshi Ishii;Hideshi Ishii;Hiroaki Nagano;Naotsugu Haraguchi

  • Two FOXP3 + CD4 + T cell subpopulations distinctly control the prognosis of colorectal cancers

    Takuro Saito;Hiroyoshi Nishikawa;Hisashi Wada;Yuji Nagano

  • CD13 is a therapeutic target in human liver cancer stem cells

    Naotsugu Haraguchi;Hideshi Ishii;Hideshi Ishii;Koshi Mimori;Fumiaki Tanaka

  • Expression of Immunoreactive E-Cadherin Adhesion Molecules in Human Cancers

    H Shiozaki;H Tahara;H Oka;M Miyata

  • Thoracic and cardiovascular surgery in Japan during 2014 : Annual report by The Japanese Association for Thoracic Surgery.

    Munetaka Masuda;Meinoshin Okumura;Yuichiro Doki

  • Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1.

    Yuko Kitagawa;Takashi Uno;Tsuneo Oyama;Ken Kato

  • Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society

    Hiroyuki Kuwano;Yasumasa Nishimura;Tsuneo Oyama;Hiroyuki Kato

  • Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer

    T Matsumura;K Sugimachi;H Iinuma;Y Takahashi

  • The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma

    Satoshi Shimizu;Tetsuo Takehara;Hayato Hikita;Takahiro Kodama

  • Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma.

    Yoshito Tomimaru;Hidetoshi Eguchi;Hiroaki Nagano;Hiroshi Wada

  • Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2

    Yuko Kitagawa;Takashi Uno;Tsuneo Oyama;Ken Kato

  • Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial

    Toshihiro Kudo;Yasuo Hamamoto;Ken Kato;Takashi Ura

  • The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells.

    Kosuke Taketo;Masamitsu Konno;Ayumu Asai;Jun Koseki

  • Defined factors induce reprogramming of gastrointestinal cancer cells

    Norikatsu Miyoshi;Hideshi Ishii;Hideshi Ishii;Ken Ichi Nagai;Hiromitsu Hoshino

  • Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers

    Y Takahashi;G Sawada;J Kurashige;R Uchi

  • Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population

    Genta Sawada;Genta Sawada;Atsushi Niida;Ryutaro Uchi;Hidenari Hirata

  • MicroRNA-125a-5p Is an Independent Prognostic Factor in Gastric Cancer and Inhibits the Proliferation of Human Gastric Cancer Cells in Combination with Trastuzumab

    Naohiro Nishida;Koshi Mimori;Muller Fabbri;Takehiko Yokobori

  • Overexpression of miR-200c Induces Chemoresistance in Esophageal Cancers Mediated Through Activation of the Akt Signaling Pathway

    Rie Hamano;Hiroshi Miyata;Makoto Yamasaki;Yukinori Kurokawa

  • MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma.

    Manabu Mikamori;Daisaku Yamada;Hidetoshi Eguchi;Shinichiro Hasegawa

Frequent Co-Authors

Masaki Mori
Masaki Mori Kyushu University
Hidetoshi Eguchi
Hidetoshi Eguchi Osaka University
Hirofumi Yamamoto
Hirofumi Yamamoto Osaka University
Hiroaki Nagano
Hiroaki Nagano Osaka University
Koshi Mimori
Koshi Mimori Kyushu University
Morito Monden
Morito Monden Osaka University
Eiichi Morii
Eiichi Morii Osaka University
Yuko Kitagawa
Yuko Kitagawa Keio University
Osamu Ishikawa
Osamu Ishikawa Gunma University
Tetsuji Naka
Tetsuji Naka Kōchi University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medicine but seeking flexible or alternative educational routes, a variety of related online programs are available. These degrees can complement or expand your career in healthcare, whether you aim for patient care, administration, or advanced nursing roles.

Aspiring healthcare managers might consider the best online mha programs. These programs focus on healthcare leadership, policy, and management, providing options that can fit around your schedule.

For registered nurses looking to earn a bachelor’s degree, rn to bsn with no clinicals programs offer an efficient path, especially for those wanting an academic upgrade without additional hands-on clinical hours.

Advanced practice nurses can pursue a Doctor of Nursing Practice (DNP). Flexible options such as the fastest dnp program and the easiest online dnp programs make it possible to achieve this highest level of nursing education quickly and conveniently.

These online pathways provide avenues to enhance your professional qualifications and expand your career opportunities within healthcare, often with greater accessibility than traditional programs.

Best Scientists Citing Yuichiro Doki

Trending Scientists